Suppr超能文献

在人阴茎细胞培养物中,5型磷酸二酯酶不会被他达拉非上调。

Phosphodiesterase type 5 is not upregulated by tadalafil in cultures of human penile cells.

作者信息

Vernet Dolores, Magee Thomas, Qian Ansha, Nolazco Gaby, Rajfer Jacob, Gonzalez-Cadavid Nestor

机构信息

Los Angeles Biomedical Research Institute-Urology, Torrance, CA, USA.

出版信息

J Sex Med. 2006 Jan;3(1):84-94; discussion 94-5. doi: 10.1111/j.1743-6109.2005.00197.x.

Abstract

OBJECTIVE

Tadalafil, a long-acting phosphodiesterase type 5 (PDE5) inhibitor, improves the erectile response by inhibiting cyclic guanosine monophosphate (cGMP) breakdown. Sustained higher levels of cGMP may hypothetically upregulate PDE5 expression and/or activity and lead to tachyphylaxis. We have investigated whether PDE5 upregulation occurs in vitro in cultures of human penile cells subjected to long-term incubation with increasing concentrations of tadalafil in the presence of a nitric oxide (NO) donor.

METHODS

Human corpora cavernosa smooth muscle cells (CSMC) and tunica albuginea fibroblasts (TAF) primary cultures were characterized by immunocytochemistry and Western blot, and incubated with graded concentrations of tadalafil for 14 days, adding S-nitroso-N-acetyl penicillamine (SNAP) as an NO donor for the last 24 hours or at time zero, and cGMP levels were measured. Incubations were repeated for 7, 10, and 14 days, in the presence of SNAP, and PDE5 was estimated by Western blot, and at 14 days, by immunocytochemistry combined with quantitative image analysis, and by real-time reverse transcriptase polymerase chain reaction (RT-PCR). Constructs of the human PDE5A promoter expressing luciferase were cloned and transfected into CSMC, and promoter activation by 8-deoxybromo-cGMP (8-Br-cGMP) was measured by luminometry.

RESULTS

Incubations of CSMC with SNAP and tadalafil up to 14 days did not upregulate PDE5 mRNA or protein levels. With TAF, PDE5 protein was also not upregulated despite a slight increase in mRNA levels. PDE5 enzyme activity was unaffected by tadalafil in either CSMC or TAF. No upregulation of the PDE5 promoter was observed with up to 2 mM 8-Br-cGMP.

CONCLUSIONS

Long-term incubation of human penile cells with tadalafil at concentrations above the in vitro IC50, and around the in vivo Cmax utilized in the clinical setting, did not upregulate PDE5A expression nor decrease cGMP levels. These data suggest that PDE5 upregulation is unlikely to occur in vivo on long-term tadalafil treatment.

摘要

目的

他达拉非是一种长效磷酸二酯酶5(PDE5)抑制剂,通过抑制环磷酸鸟苷(cGMP)分解来改善勃起反应。持续较高水平的cGMP可能会假设性地上调PDE5表达和/或活性,并导致快速耐受性。我们研究了在一氧化氮(NO)供体存在的情况下,人阴茎细胞培养物中,随着他达拉非浓度增加进行长期孵育时,体外是否会发生PDE5上调。

方法

通过免疫细胞化学和蛋白质印迹对人海绵体平滑肌细胞(CSMC)和白膜成纤维细胞(TAF)原代培养物进行鉴定,并与不同浓度的他达拉非孵育14天,在最后24小时或零时添加S-亚硝基-N-乙酰青霉胺(SNAP)作为NO供体,然后测量cGMP水平。在SNAP存在的情况下,分别进行7、10和14天的孵育,通过蛋白质印迹估计PDE5,并在14天时通过免疫细胞化学结合定量图像分析以及实时逆转录聚合酶链反应(RT-PCR)进行估计。克隆表达荧光素酶的人PDE5A启动子构建体并转染到CSMC中,通过发光法测量8-脱氧溴-cGMP(8-Br-cGMP)对启动子的激活作用。

结果

CSMC与SNAP和他达拉非孵育长达14天并未上调PDE5 mRNA或蛋白质水平。对于TAF,尽管mRNA水平略有增加,但PDE5蛋白质也未上调。PDE5酶活性在CSMC或TAF中均不受他达拉非影响。高达2 mM的8-Br-cGMP未观察到PDE5启动子上调。

结论

人阴茎细胞在高于体外IC50且接近临床使用的体内Cmax浓度下长期与他达拉非孵育,并未上调PDE5A表达,也未降低cGMP水平。这些数据表明,长期使用他达拉非治疗在体内不太可能发生PDE5上调。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验